MRI contrast-enhancing agents clinical trials
3 indexed studies · 1 currently recruiting
- Active not recruitingPHASE3
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
This study is looking at a new medicine called frexalimab for people aged 18-55 with certain types of Multiple Sclerosis (MS). It compares frexalimab to an existing MS medicine, teriflunomide, to see how well it stops MS relapses and if it's safe.
For: Multiple SclerosisUnited States · Argentina · Austria - Active not recruitingPHASE3
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
This study is testing a new drug called frexalimab for people with a type of multiple sclerosis (MS) called non-relapsing secondary progressive MS (nrSPMS). Researchers want to see if it can slow down MS progression and if it's safe. It's compared to a dummy drug (placebo).
For: Multiple SclerosisUnited States · Argentina · Australia - Enrolling by invitationNA
OE MRI to Predict Treatment Response After TACE in HCC Patients
This study looks at a special MRI scan before and after treatment for a type of liver cancer called HCC. We want to see if this MRI can predict how well the treatment works by checking how much oxygen gets into the tumour.
For: HCC - Hepatocellular Carcinoma · TACE · SIRTCanada